Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(acetylamino)-4-((aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-7-o-methyl-d-glycero-d-galacto-non-2-enonic Acid
2. Laninamivir Octanoate
3. Laninamivir Octanoate Hydrate
4. Laninamivir Octanoate Monohydrate
5. Laninamivir Trifluoroacetate
6. R 125489
7. R-125489
8. R125489
1. 203120-17-6
2. R-125489
3. (2r,3r,4s)-3-acetamido-4-(diaminomethylideneamino)-2-[(1r,2r)-2,3-dihydroxy-1-methoxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic Acid
4. B408iw3gl5
5. Laninamivir (inn)
6. D-glycero-d-galacto-non-2-enonic Acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-o-methyl-
7. Laninamivir [inn]
8. (2r,3r,4s)-3-acetamido-2-((1r,2r)-2,3-dihydroxy-1-methoxypropyl)-4-guanidino-3,4-dihydro-2h-pyran-6-carboxylic Acid
9. (4s,5r,6r)-5-acetamido-4-carbamimidamido-6-((1r,2r)-3-hydroxy-2-methoxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic Acid
10. 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-7-o-methyl-d-glycero-d-galacto-non-2-enonic Acid
11. Laninamivir [inn:jan]
12. Laninamivir (cs-8958)
13. Unii-b408iw3gl5
14. Lani
15. Laninamivir [mi]
16. Laninamivir [mart.]
17. Laninamivir [who-dd]
18. Chembl466246
19. Schembl12284832
20. Dtxsid60942457
21. Chebi:177801
22. Bcpp000190
23. Glxc-15033
24. Bcp27633
25. Ex-a4019
26. Zinc3985629
27. Bdbm50009296
28. Akos015850995
29. Akos032947260
30. Bcp9000836
31. Db12791
32. (2r,3r,4s)-3-acetamido-2-[(1r,2r)-2,3-dihydroxy-1-methoxy-propyl]-4-guanidino-3,4-dihydro-2h-pyran-6-carboxylic Acid
33. (4s,5r,6r)-5-acetamido-4-guanidino-6-((1r,2r)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic Acid
34. Ac-36457
35. Hy-14818
36. Cs-0003575
37. C21557
38. D09410
39. 120l176
40. A814430
41. Q6487096
42. R 125489r 125489
43. (4s,5r,6r)-5-acetamido-4-guanidino-6- ((1r,2r)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic Acid
44. 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-o-methyl-d-glycero-d-galacto-non-2-enonic Acid
45. 5-acetylamino-4-(diaminomethyl-amino)-6-(2,3-dihydroxy-1-methoxy-propyl)-5,6-dihydro-4h-pyran-2-carboxylic Acid
| Molecular Weight | 346.34 g/mol |
|---|---|
| Molecular Formula | C13H22N4O7 |
| XLogP3 | -3.2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 346.14884905 g/mol |
| Monoisotopic Mass | 346.14884905 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 532 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AH - Neuraminidase inhibitors
J05AH04 - Laninamivir
Global Sales Information
Market Place
ABOUT THIS PAGE
28
PharmaCompass offers a list of Laninamivir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Laninamivir manufacturer or Laninamivir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Laninamivir manufacturer or Laninamivir supplier.
PharmaCompass also assists you with knowing the Laninamivir API Price utilized in the formulation of products. Laninamivir API Price is not always fixed or binding as the Laninamivir Price is obtained through a variety of data sources. The Laninamivir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Laninamivir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Laninamivir, including repackagers and relabelers. The FDA regulates Laninamivir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Laninamivir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Laninamivir supplier is an individual or a company that provides Laninamivir active pharmaceutical ingredient (API) or Laninamivir finished formulations upon request. The Laninamivir suppliers may include Laninamivir API manufacturers, exporters, distributors and traders.
Laninamivir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Laninamivir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Laninamivir GMP manufacturer or Laninamivir GMP API supplier for your needs.
A Laninamivir CoA (Certificate of Analysis) is a formal document that attests to Laninamivir's compliance with Laninamivir specifications and serves as a tool for batch-level quality control.
Laninamivir CoA mostly includes findings from lab analyses of a specific batch. For each Laninamivir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Laninamivir may be tested according to a variety of international standards, such as European Pharmacopoeia (Laninamivir EP), Laninamivir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Laninamivir USP).
